Skip to main content

Michael Sardano

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Michael Sardano

Michael Sardano is recorded as General Counsel and Board Member at Sensus Healthcare, Inc. (SRTS). Sensus Healthcare, Inc. reported in an 8-K filed January 18, 2024 that Michael Sardano was appointed director, effective February 1, 2024. The proxy statement of Sensus Healthcare, Inc. reports total compensation of $1,213,917 for Michael Sardano in fiscal 2025, including a base salary of $500,000. Disclosed compensation is on record for 7 fiscal years. Michael Sardano has spoken on 15 earnings calls across 1 company, most recently for Sensus Healthcare, Inc. on August 13, 2026.

“On January 11, 2024, the Board of Directors (the "Board") of Sensus Healthcare, Inc. (the "Company") appointed Michael Sardano ("Mr. Sardano") as a director, effective February 1, 2024.”
Sensus Healthcare, Inc. Form 8-K, filed January 18, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Sensus Healthcare, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Sensus Healthcare, Inc. (SRTS) $500,000 $1,213,917
2024 Sensus Healthcare, Inc. (SRTS) $350,000 $1,275,078
2023 Sensus Healthcare, Inc. (SRTS) $300,000 $452,523
2022 Sensus Healthcare, Inc. (SRTS) $225,000 $404,739
2021 Sensus Healthcare, Inc. (SRTS) $190,000 $426,973
2020 Sensus Healthcare, Inc. (SRTS) $190,000 $261,072
2019 Sensus Healthcare, Inc. (SRTS) $175,000 $228,859

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Show 4 earlier activities